Status:

COMPLETED

Applying Pharmacogenetic Algorithms to Individualize Dosing of Warfarin

Lead Sponsor:

Intermountain Health Care, Inc.

Conditions:

Thromboembolism

Eligibility:

All Genders

18+ years

Phase:

PHASE2

PHASE3

Brief Summary

The purpose of this study is to determine whether DNA analysis improves the efficiency of dosing and safety in patients who are being started on warfarin therapy.Warfarin, a blood thinner (anticoagula...

Detailed Description

Study Objectives: The specific objectives of CoumaGen-II to be tested are: 1. To apply routine pharmacogenetic (PG)-guided dosing of warfarin in clinical practice at Intermountain Healthcare facilit...

Eligibility Criteria

Inclusion

  • New participants will be those \>=18 years old who are appropriate candidates for and being initiated on warfarin therapy with target international normalized prothrombin time ratio (INR) range of either 2-3 or 2.5-3.5 and with intent to be treated for at least 1 month and willing to sign informed consent.
  • Those with target INR 2.5-3.5 may be enrolled with dose adjustment for this higher target per Gage et-al. (i.e., 11% increase in dose).
  • Dose modification also will be made for amiodarone based on prior, published experience (i.e., 22% decrease in dose).

Exclusion

  • Those not appropriate for warfarin (e.g., pregnancy) or for pharmacogenetic (PG)-guided dosing for any reason,
  • Those having received rifampin within 3 weeks,
  • Those with severe co-morbidities (e.g., creatinine \> 2.5,hepatic insufficiency, active malignancy, advanced physiological age, noncompliance risk, expected survival \<6 months), and
  • Physician or patient preference.

Key Trial Info

Start Date :

August 1 2008

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

June 1 2011

Estimated Enrollment :

2415 Patients enrolled

Trial Details

Trial ID

NCT00927862

Start Date

August 1 2008

End Date

June 1 2011

Last Update

September 25 2012

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Intermountain Healthcare Hospitals and Clinics

Salt Lake City, Utah, United States, 84107